The Newcastle upon Tyne Hospitals NHS Foundation Trust is the country’s best performing trust for volume of clinical research for the seventh year running.
It topped the national league tables for the number of health research studies with a total of 550 studies supported by the trust, exceeding last year’s record of 528.
The table also shows that 16,884 patients at the trust helped to shape the NHS of tomorrow by taking part in clinical research, a rise of 34% since the year before.
The 2017/18 NIHR Research Activity League Table is published by the National Institute for Health Research (NIHR). It highlights the extent of NHS research taking place in England, and the number of participants being recruited into studies.
Dame Jackie Daniel, chief executive, Newcastle upon Tyne Hospitals NHS Foundation Trust (NUTH), said: “We’re thrilled to be leading the way nationally in clinical research once again. As a Trust, we are committed to delivering the best possible care to patients by investing in research which can help improve the lives of people not just regionally, but also nationally and internationally.
“If it wasn’t for the continued hard work and dedication from our team of medical professionals we wouldn’t be able to achieve all that we do in the clinical research field. Special recognition also has to go to all of the patients across the region who give their time to enable us to carry out this important research. Without them, none of this would be possible.”
Biomedical research in Newcastle
The NIHR Newcastle Biomedical Research Centre (BRC) is a partnership between the Newcastle upon Tyne Hospitals Trust and Newcastle University, and is tasked with carrying out translational research that benefits patients. The outstanding results in this year’s Research Activity League Table reflect the drive to include patients in on going research, as well as the commitment of the Trust to deliver on key infrastructure like the NIHR Newcastle BRC.
Professor Avan Sayer, Director of the NIHR Newcastle BRC said: “We’re very proud to be a part of the Newcastle Hospitals research success, working with patients and the public to see research activity developing year on year.
Commercial research activity is also gaining momentum. The Newcastle trust reported the country’s biggest increase in research activity involving commercial studies, up by 22% from 117 to 143, reflecting the city’s reputation as a global hub for the fast-growing life sciences sector.
Collaboration with industry is vital to enable the NHS to deliver first class clinical research, speeding up the development and availability of new treatments, therapies and diagnostics.
Dr Jonathan Sheffield OBE, chief executive officer of the NIHR Clinical Research Network (CRN) said: “By taking part in life sciences industry studies, patients are participating in new and innovative forms of treatment which will provide evidence for future improved care for all patients. The knowledge gained could provide the evidence to license new treatments in the NHS securing healthy lives for future generations.
“Partnerships between the NHS and the life sciences industry bring a range of benefits to the healthcare sector – giving trusts access to new treatments and funding for health research, while also boosting the wider economy each year through the development of cutting edge medical innovations.”
The NIHR League Table can be accessed from the NIHR website
To find out more about clinical trials available in your area visit the UK Clinical Trials Gateway